DUKE UNIVERSITY
Manipulating Sex Hormone Signaling for Therapeutic Benefit in Liver Cancer
Manipulating Sex Hormone Signaling for Therapeutic Benefit in Liver Cancer is a funding opportunity from DUKE UNIVERSITY, up to 86824, closing March 9, 2028.
Mar 9, 2028
(587d left)Overview
Project Summary/Abstract Hepatocellular carcinoma (HCC) is on track to surpass breast, prostate, and colorectal cancer to become the third-leading cause of cancer death in the United States by 2040. HCC-related deaths in men outnumber those in women by more than 3:1 and this is thought to be due to male hormone…